Madrigal Pharmaceuticals (MDGL) Receivables - Other (2015)

Madrigal Pharmaceuticals (MDGL) posted quarterly Receivables - Other of $7332.0 for Q4 2015.

Madrigal Pharmaceuticals (MDGL) Receivables - Other (2015) Analysis & Trends

Madrigal Pharmaceuticals (MDGL) has reported Receivables - Other for 1 consecutive years, with $7332.0 the latest figure, recorded in Q4 2015.

In Q4 2015, Receivables - Other changed N/A year-over-year to $7332.0; the TTM figure through Dec 2015 stood at $7332.0 (changed N/A YoY), while the FY2015 annual figure was $7332.0, changed N/A from the prior year.
Receivables - Other steadied at $7332.0 in Q4 2015 per MDGL's latest filing.
Across five years, Receivables - Other topped out at $7332.0 in Q4 2015 and bottomed at $7332.0 in Q4 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Madrigal Pharmaceuticals	14.79 Bn	13.95 Bn	-

Historic Data

Download Data

Date	Value
Dec 31, 2015	7,332.00
Dec 31, 2015	7,332.00